Scarica l'app Stockscreener
71.31
1.48%
1.04
Precedente Chiudi:
$70.27
Aprire:
$70.69
Volume 24 ore:
340.05K
Relative Volume:
0.52
Capitalizzazione di mercato:
$3.93B
Reddito:
$76.81M
Utile/perdita netta:
$-162.42M
Rapporto P/E:
-23.85
EPS:
-2.99
Flusso di cassa netto:
$-122.49M
1 W Prestazione:
+5.50%
1M Prestazione:
+11.37%
6M Prestazione:
+13.20%
1 anno Prestazione:
+13.75%
Intervallo 1D:
$69.50
$71.57
Intervallo di 1 settimana:
$66.52
$71.70
Portata 52W:
$47.86
$107.37
Arcellx Inc Stock (ACLX) Company Profile
Nome
Arcellx Inc
Settore
Industria
Telefono
240-327-0603
Indirizzo
800 BRIDGE PARKWAY, REDWOOD CITY
Confronta ACLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACLX
Arcellx Inc
|
71.31 | 3.87B | 76.81M | -162.42M | -122.49M | -2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcellx Inc Stock (ACLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Iniziato | Citigroup | Buy |
| 2024-10-08 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-03 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-31 | Iniziato | Piper Sandler | Overweight |
| 2024-03-07 | Iniziato | Morgan Stanley | Overweight |
| 2024-01-04 | Reiterato | Needham | Buy |
| 2023-12-19 | Iniziato | Scotiabank | Sector Outperform |
| 2023-10-30 | Iniziato | TD Cowen | Outperform |
| 2023-10-17 | Iniziato | UBS | Buy |
| 2023-05-18 | Iniziato | Truist | Buy |
| 2023-04-14 | Iniziato | Robert W. Baird | Outperform |
| 2023-03-14 | Iniziato | Stifel | Buy |
| 2023-02-13 | Iniziato | H.C. Wainwright | Buy |
| 2022-12-13 | Ripresa | BofA Securities | Buy |
| 2022-10-31 | Iniziato | Guggenheim | Buy |
| 2022-10-27 | Iniziato | Needham | Buy |
| 2022-07-20 | Iniziato | Canaccord Genuity | Buy |
| 2022-03-01 | Iniziato | BofA Securities | Buy |
| 2022-03-01 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Arcellx Inc Borsa (ACLX) Ultime notizie
Is Arcellx Inc. a growth stock or a value stockExceptional stock performance - jammulinksnews.com
How does Arcellx Inc. compare to its industry peersMaximize returns with strategic portfolio planning - jammulinksnews.com
How volatile is Arcellx Inc. stock compared to the marketFree Capital Efficiency Planning - jammulinksnews.com
What are analysts’ price targets for Arcellx Inc. in the next 12 monthsInvest confidently with professional market insights - jammulinksnews.com
Is it the right time to buy Arcellx Inc. stockMaximize your returns with portfolio optimization - jammulinksnews.com
How does Arcellx Inc. generate profit in a changing economyGet timely market insights for better trades - jammulinksnews.com
What makes Arcellx Inc. stock price move sharplyBuild a portfolio for long-term financial success - jammulinksnews.com
Arcellx Inc. Stock Performance After Earnings: Historical InsightsConsistent Growth Alert - Newser
What are Arcellx Inc. company’s key revenue driversAchieve triple-digit returns with smart investing - jammulinksnews.com
Why Arcellx Inc. stock attracts strong analyst attentionFree Smart Money Group - Newser
Arcellx, Inc. (NASDAQ:ACLX) Holdings Reduced by New York State Common Retirement Fund - Defense World
What analysts say about Arcellx Inc. stockRapid wealth multiplication - PrintWeekIndia
What drives Arcellx Inc. stock priceSuperior portfolio returns - PrintWeekIndia
What analysts say about Arcellx Inc. stock outlookBreakthrough investment results - jammulinksnews.com
How to Take Advantage of moves in (ACLX) - news.stocktradersdaily.com
Victory Capital Management Inc. Sells 6,073 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx, Inc. (NASDAQ:ACLX) Given Average Recommendation of “Buy” by Analysts - Defense World
Arcellx Inc. Stock Analysis and ForecastConsistently exceptional gains - jammulinksnews.com
Is Arcellx Inc. a good long term investmentFree Trading Strategy Suggestions - jammulinksnews.com
Bank of New York Mellon Corp Cuts Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Principal Financial Group Inc. Sells 184 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Xponance Inc. Acquires 190 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx Advances Phase 3 Study for Multiple Myeloma Treatment - The Globe and Mail
There's Reason For Concern Over Arcellx, Inc.'s (NASDAQ:ACLX) Price - 富途牛牛
Teacher Retirement System of Texas Decreases Stake in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx; Anito-Cel With D-Domain Differentiation Looks To Capture R/R MM Market (ACLX) - Seeking Alpha
Arcellx Inc Azioni (ACLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):